Research antibodies have gained immense popularity in the life sciences industry owing to their diverse applications in various research activities such as drug discovery and development, genomics, proteomics, and cell biology. Research antibodies aid in detecting, quantifying, and identifying specific proteins and other molecules of interest in numerous research fields such as immunology, oncology, neurobiology, and infectious diseases. The increased investments in research and development activities from both private and public organizations are expected to boost demand for high-quality research antibodies. Furthermore, growing focus on personalized medicine and complexity of diseases have augmented the scope of various life science researches, thereby propelling the global research antibodies market. The global Research Antibodies Market is estimated to be valued at US$ 3785.05 Bn in 2023 and is expected to exhibit a CAGR of 7.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Drug development process requires extensive research at various stages such as target identification and validation, hit generation, lead identification and optimization, preclinical and clinical studies. During these research phases, research antibodies play a crucial role in target identification and validation. Thus, with rising investments towards development of novel drug molecules, demand for high-quality research antibodies is expected to propel over the forecast period. For instance, according to PhRMA (Pharmaceutical Research and Manufacturers of America) survey, biopharmaceutical companies in the U.S. invested over US$ 79.6 billion in research and development in 2018, demonstrating increased focus on developing novel treatment options.
Segment Analysis
The global research antibodies market is dominated by primary antibodies which account for over 60% of the market share. Primary antibodies are the building blocks for detection of biomarkers and antigens and are widely used across various research areas such as neurobiology, immunology and cancer research. Their ability to specifically recognize and bind to target antigens with high affinity makes them an indispensable research tool.
Key Takeaways
The Global Research Antibodies Market Size is expected to witness high growth over the forecast period.
Regional analysis: North America currently dominating the market with the largest share owing to presence of leading life sciences research companies and research institutes. The region is expected to maintain its leading position during the forecast period supported by rising government and private funding for biomedical research.
Key players operating in the research antibodies market are Zoetis Inc., Elanco Animal Health, MSD Animal Health, Benchmark Holdings, Phibro Animal Health Corporation, Intervet Inc., Norvartis, Merck Animal Health, Novartis AG, Pharmaq AS, AquaBounty Technologies, Alltech, Skretting, Nutreco, Biomin.
Get More Insights On This Topic: https://www.newsstatix.com/research-antibodies-market-size-share-analysis-2023-2030/
Comments
0 comment